270.8

+1.58%↑

SAN

78.73

-1.04%↓

MRK1

106.5

-0.47%↓

SHL.DE

47.61

-0.48%↓

ARGX

631.8

-0.94%↓

270.8

+1.58%↑

SAN

78.73

-1.04%↓

MRK1

106.5

-0.47%↓

SHL.DE

47.61

-0.48%↓

ARGX

631.8

-0.94%↓

270.8

+1.58%↑

SAN

78.73

-1.04%↓

MRK1

106.5

-0.47%↓

SHL.DE

47.61

-0.48%↓

ARGX

631.8

-0.94%↓

270.8

+1.58%↑

SAN

78.73

-1.04%↓

MRK1

106.5

-0.47%↓

SHL.DE

47.61

-0.48%↓

ARGX

631.8

-0.94%↓

270.8

+1.58%↑

SAN

78.73

-1.04%↓

MRK1

106.5

-0.47%↓

SHL.DE

47.61

-0.48%↓

ARGX

631.8

-0.94%↓

Kodu・Aktsiate loetelu・Nanobiotix

N
Nanobiotix

Suletud

8.48 6.53

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.81

Max

8.51

Põhinäitajad
By Trading Economics
Sissetulek	-46M
Müük	-21M
Kasumimarginaal	221.361
Töötajad	108
EBITDA	-38M

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	24. sept 2025

Turustatistika
By TradingEconomics
Turukapital	390M
Eelmine avamishind	1.95
Eelmine sulgemishind	8.48

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. sept 2025, 17:03 UTC

Suurimad hinnamuutused turgudel

BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment

16. sept 2025, 16:49 UTC

Suurimad hinnamuutused turgudel

Omandamised, ülevõtmised, äriostud

GD Culture Shares Drop After Deal for Pallas Capital

16. sept 2025, 16:11 UTC

Suurimad hinnamuutused turgudel

Corbus Shares Rise on FDA Fast-Track Designation for Cancer Drug

16. sept 2025, 23:40 UTC

Market Talk

Nikkei May Decline as Yen Strengthens -- Market Talk

16. sept 2025, 23:34 UTC

Market Talk

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

16. sept 2025, 23:20 UTC

Market Talk

Restaurant Brands NZ Can Outperform When Cycle Turns -- Market Talk

16. sept 2025, 21:10 UTC

Omandamised, ülevõtmised, äriostud

U.S. Investors, Trump Close In on TikTok Deal With China -- WSJ

16. sept 2025, 20:51 UTC

Market Talk

U.S. Home Sales, New Home Listings Fall in August -- Market Talk

16. sept 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

16. sept 2025, 20:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

16. sept 2025, 20:25 UTC

Tulu

The AI Trade Has Stocks Near Highs Again. Some Tech Names Remain on the Sidelines -- Barrons.com

16. sept 2025, 20:24 UTC

Tulu

These Stocks Moved the Most Today: Oracle, Tesla, Alphabet, Dave & Buster's, Chipotle, and More -- Barrons.com

16. sept 2025, 19:19 UTC

Market Talk

U.S. Natural Gas Futures Extend Winning Streak -- Market Talk

16. sept 2025, 18:52 UTC

Market Talk

Oil Futures Advance on Russia Concerns, Weak Dollar -- Market Talk

16. sept 2025, 18:44 UTC

Market Talk

Global Equities Roundup: Market Talk

16. sept 2025, 18:44 UTC

Market Talk

EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk

16. sept 2025, 18:40 UTC

Omandamised, ülevõtmised, äriostud

Details Emerge on U.S.-China TikTok Deal -- WSJ

16. sept 2025, 18:38 UTC

Market Talk

Meta Seen With Long-Term Opportunity to Lead in Smart Glasses -- Market Talk

16. sept 2025, 18:19 UTC

Market Talk

Gold Settles at New High Ahead of Fed Decision -- Market Talk

16. sept 2025, 18:01 UTC

Market Talk

U.S. Dollar Weakness Supports Oil's Gains -- Market Talk

16. sept 2025, 17:34 UTC

Market Talk

Any Question the Bank of Canada Will Cut Now Look to Have Vanished -- Market Talk

16. sept 2025, 16:53 UTC

Tulu

Software Companies Are Fighting Back With AI. The Stocks Are Still Hurting. -- Barrons.com

16. sept 2025, 16:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

16. sept 2025, 16:15 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Global Commodities Roundup: Market Talk

16. sept 2025, 16:09 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Global Energy Roundup: Market Talk

16. sept 2025, 16:09 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Canada Industry Minister to Meet Mining CEOs on Merger -- Market Talk

16. sept 2025, 15:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. sept 2025, 15:35 UTC

Market Talk

Gold Soars Past $3,700 Ahead of Fed Decision -- Market Talk

16. sept 2025, 15:22 UTC

Market Talk

More Investors Think Dollar is Overvalued in Latest BofA Survey -- Market Talk

16. sept 2025, 15:21 UTC

Market Talk

Sterling Considered Most Overvalued in Nearly 10 Years -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.